Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
White mulberry is a deciduous shrub or tree (*Morus alba*) native to China and used in traditional medicine for over 3,000 years[1][3][4]. Its leaves, fruit, bark, and root are used in dietary supplements and traditional remedies. Active components include flavonoids, alkaloids, phenolic acids, and other phytochemicals with reported antioxidant, anti-inflammatory, antidiabetic, and lipid-lowering activities[6]. Compounds in white mulberry, especially the leaves, delay carbohydrate digestion and absorption, which may help regulate postprandial blood sugar[1][5][7]. Human studies suggest potential efficacy for blood glucose and cholesterol reduction in type 2 diabetes, though overall clinical evidence remains limited and more research is needed[4][5]. Other traditional and supplement uses include weight management, cardiovascular health, treating cough and cold symptoms, and anti-cancer effects, but robust clinical proof is lacking[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on white mulberry.